First vaccine dose could alleviate long Covid symptoms, study suggests

A first vaccine dose appears to alleviate symptoms in long Covid sufferers, a new study has suggested, although it is unclear whether this improvement lasts until a second dose. People aged 18 to 69 who had received a first dose were 12.8 per cent less likely to report that they were still experiencing persistent symptoms, according to experimental findings published by the Office for National Statistics (ONS). A second dose was associated with a further 8.8 per cent drop, with “statistical evidence” of a sustained improvement afterwards.